Stefrab-LS
Rabeprazole 20 mg +Levosulpiride 75 mg Sustained Release Capsules
The Clinically Excellent Therapy to Control GI Discomforts
Rabeprazole: Potent & Effective PPI
– Rabeprazole 20 mg is sufficient to block the maximum amount of proton pumps
– Rapidly suppresses acid & ensures sustained action
– Effectively controls reflux esophagitis maa 0r a
– Ensures prolonged safety in lona term maintenance therapy
Levosulpiride Superior to Domperidone & Other Prokinetics
-Exerts prokinetic action thrOugh dual mechanism:
1) as a D dopamine receptor antagonist and
2) as a serotonin SHTa receptor aganist,
– At a dosage of 75mg SR daily, Ievosulpiride accelerates gastric
and gallbladder emptying.
– More effective in reducing symptoms of dyspepsia, as compared
to other dopamine antagonists
